Spots Global Cancer Trial Database for A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors
Official Title: A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors
Study ID: NCT00869388
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate toxicity associated with escalating doses of rBBX-01 given bi-weekly to patients with solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Washington University School of Medicine, St. Louis, Missouri, United States
Contact Details
Name: Premal Thaker, M.D.
Affiliation: Washington University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
